Business Wire
-
Babson Diagnostics To Launch Transformative Blood Testing Service With Leading Retail Partners
3/21/2024
Babson Diagnostics, a science-first health technology company, announced today that it will launch BetterWay blood testing with three retail partners in Austin and San Antonio.
-
Spectrum Solutions Releases The New SimplyPERIO Saliva Test Powered By SimplyTest
3/21/2024
Spectrum Solutions, saliva diagnostic biotech leader, today announced the official release of a new saliva diagnostic testing innovation, SimplyPERIO.
-
Genseq Selects Sapio LIMS To Power Best-In-Class Next-Generation Sequencing Services
3/18/2024
Genseq, a Dublin-based, CAP-accredited laboratory providing a range of services for biopharma and clinical research, has adopted the science-aware lab informatics platform from Sapio Sciences to manage its next-generation sequencing (NGS) and biobanking workflows.
-
Revvity Introduces New Workflow To Accelerate Newborn Sequencing Research
3/15/2024
Revvity, Inc. today announced the introduction of a flexible end-to-end workflow solution for newborn research, enabling users to utilize different instruments, reagents and databases based on a lab’s needs.
-
Fabric Genomics Partners With Intermountain Children’s Health To Enhance Precision Diagnosis Of Infants And Children Using Whole Genome Sequencing From Broad Clinical Labs
3/13/2024
Fabric Genomics, the leader in artificial intelligence (AI)-powered next generation sequencing interpretation, is announcing a new partnership with Intermountain Children’s Health to analyze the whole genomes of children sequenced by the Broad Clinical Labs to help speed diagnosis of kids who may have genetic diseases.
-
Beckman Coulter And Fujirebio Expand Partnership To Develop Patient-Friendly, Blood-Based Neurodegenerative Disease Diagnostics
3/12/2024
Beckman Coulter Diagnostics, a clinical diagnostics leader, and Fujirebio, a leader in neurological markers and In Vitro Diagnostic (IVD) manufacturing, today announced an expansion of their partnership focused on development, manufacturing and clinical adoption of neurodegenerative disease assays.
-
Wolters Kluwer Strengthens Clinical GenAI Market Leadership With AI Labs Powered By Uptodate
3/11/2024
Wolters Kluwer Health today announced several key milestones for AI Labs, the Clinical Generative AI (GenAI) beta launched in 2023 and powered by UpToDate, the globally trusted clinical decision support (CDS) solution.
-
QuidelOrtho Receives Health Canada Approval For Quidel Triage PLGF Test For Laboratory Use In Canada
3/6/2024
QuidelOrtho Corporation (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, has received approval from Health Canada for its Triage PLGF test for laboratory use in Canada.
-
New Data Demonstrate Sunbird Bio’s APEX Diagnostic Test Accurately Differentiates Key Alzheimer’s Disease Biomarker In Blood
3/5/2024
Sunbird Bio, a biotechnology company developing proprietary protein- and blood-based technologies to improve diagnosis and treatment of neurological disorders and early-stage cancer, today announced new data demonstrating that their APEX (Amplified Plasmonic EXosomes) amyloid beta (Aβ) test, the company’s investigational blood-based diagnostic in Alzheimer’s disease, effectively discriminated between patients who were positive versus negative for Aβ on positron emission tomography (PET) scans.
-
Bruker Announces Share Purchase Agreement To Acquire Molecular Diagnostics Innovator ELITechGroup
2/28/2024
Bruker Corporation announced today that it has entered into a definitive share purchase agreement with TecFin S.à r.l., a controlled affiliate of PAI Partners, a pre-eminent private equity firm, to acquire ELITechGroup, for €870M in cash, excluding the carved out ELITech clinical chemistry business.